Archive for December, 2011:

Kinase Inhibitor Akt Inhibitor VQD-002 Is commonly used to deal with numerous cancer including ovarian cancer

VioQuest Prescription medications introduced preclinical data showing their novel AKT inhibitor VQD-002 Kinase Inhibitor  provides complete benefit together with numerous cancer remedies including trastuzumab , dasatinib , cisplatin, while some. The outcome were presented in lots of poster presentations inside the Annual Meeting within the American Association for Cancer Research (AACR) in Hillcrest. VQD-002 (triciribine

(Read More…)

New Treatment Regimen Shows mixing PARP inhibitor with temozolomide benefit In Advanced Colon Cancer

A brand new treatment regimen for patients with metastatic colon cancer seems to provide clinical benefit even if used after multiple other remedies have unsuccessful, say research doctors at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown College Clinic. The study team discovered that mixing a PARP inhibitor with chemotherapy (temozolomide) offers significant benefit in

(Read More…)

The Specific Kinase Inhibitors PI3 kinase inhibitor for the treatment of cancer

Calistoga Pharmaceutical drugs, Corporation, the best choice in the introduction of isoform-selective PI3 kinase inhibitors for treating cancer and inflammatory illnesses, today introduced the presentation of information showing the Company’s dental, p110δ(delta) selective PI3 kinase inhibitor CAL-101 has broad preclinical anti-tumor activity against a variety of hematologic malignancies. Data were presented within an dental presentatiSeparate

(Read More…)

© Apoptosis|apoptosis inhibitor|apoptosis pathway
CyberChimps